Bright Minds Biosciences

Forecast & Rating7 analysts currently cover Bright Minds Biosciences, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $169.51, about 122.8% upside from the current price of $76.09. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 100.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Bright Minds Biosciences closely still see room for the stock to rise. Data as of Aug 20, 2026; for reference only and not investment advice.